Suppr超能文献

人外周血单个核细胞对利什曼原虫前鞭毛体全细胞、颗粒性及可溶性提取物的体外反应。

In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes.

作者信息

Telino E, De Luca P M, Matos D C S, Azeredo-Coutinho R B, Meirelles M N, Conceição-Silva F, Schubach A, Mendonça S C F

机构信息

Department of Immunology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.

出版信息

Clin Exp Immunol. 2006 Feb;143(2):338-44. doi: 10.1111/j.1365-2249.2006.02995.x.

Abstract

Whole-cell and soluble extracts of Leishmania promastigotes have both been used as skin test antigens and have also been tested as vaccine candidates. However, the differences in antigenicity between soluble and particulate Leishmania fractions are not known. We evaluated in vitro responses of PBMC from 30 American tegumentary leishmaniasis (ATL) patients and seven noninfected donors to different antigen preparations from Leishmania promastigotes, namely Leishmania amazonensis and L. braziliensis whole-cell extracts, as well as soluble and particulate fractions of L. amazonensis. All Leishmania antigen preparations stimulated significantly higher proliferation and interferon (IFN)-gamma production (but not interleukin (IL)-10 production) in PBMC from the leishmaniasis patients than in cells from the control subjects. The L. braziliensis whole-cell extract stimulated significantly higher cell proliferation and IFN-gamma production than the L. amazonensis whole-cell extract in the group of patients but not in the control group. This result can be explained by the fact that the patients were infected with L. braziliensis. Again in the group of patients, the PBMC proliferative responses as well as the levels of IFN-gamma and IL-10 stimulated by L. amazonensis whole-cell extract were significantly greater than those elicited by the L. amazonensis soluble fraction but were not significantly different from those elicited by the L. amazonensis particulate fraction. We found a higher antigenicity of the particulate fraction as compared to the soluble fraction, what suggests that the antigens present in the particulate fraction account for most of the antigenicity of whole-cell Leishmania promastigote antigen extracts.

摘要

利什曼原虫前鞭毛体的全细胞提取物和可溶性提取物都已被用作皮肤试验抗原,并且也作为候选疫苗进行了测试。然而,可溶性和颗粒性利什曼原虫组分之间的抗原性差异尚不清楚。我们评估了30名美洲皮肤利什曼病(ATL)患者和7名未感染供体的外周血单核细胞(PBMC)对来自亚马逊利什曼原虫和巴西利什曼原虫前鞭毛体的不同抗原制剂的体外反应,即亚马逊利什曼原虫和巴西利什曼原虫的全细胞提取物,以及亚马逊利什曼原虫的可溶性和颗粒性组分。与对照组细胞相比,所有利什曼原虫抗原制剂均能显著刺激利什曼病患者PBMC中更高的增殖和干扰素(IFN)-γ产生(但不刺激白细胞介素(IL)-10产生)。在患者组中,巴西利什曼原虫全细胞提取物刺激的细胞增殖和IFN-γ产生显著高于亚马逊利什曼原虫全细胞提取物,但在对照组中并非如此。这一结果可以用患者感染了巴西利什曼原虫这一事实来解释。同样在患者组中,亚马逊利什曼原虫全细胞提取物刺激的PBMC增殖反应以及IFN-γ和IL-10水平显著高于亚马逊利什曼原虫可溶性组分刺激的反应,但与亚马逊利什曼原虫颗粒性组分刺激的反应无显著差异。我们发现颗粒性组分的抗原性高于可溶性组分,这表明颗粒性组分中存在的抗原占利什曼原虫前鞭毛体全细胞抗原提取物大部分的抗原性。

相似文献

5
Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?
Clin Exp Immunol. 2007 Sep;149(3):440-4. doi: 10.1111/j.1365-2249.2007.03436.x. Epub 2007 Jul 5.

引用本文的文献

1
Cutaneous Leishmaniasis Vaccination: A Matter of Quality.
Front Immunol. 2016 Apr 21;7:151. doi: 10.3389/fimmu.2016.00151. eCollection 2016.
2
American tegumentary leishmaniasis: T-cell differentiation profile of cutaneous and mucosal forms-co-infection with Trypanosoma cruzi.
Med Microbiol Immunol. 2016 Aug;205(4):353-69. doi: 10.1007/s00430-016-0455-0. Epub 2016 Apr 4.
3
Ultradeformable Archaeosomes for Needle Free Nanovaccination with Leishmania braziliensis Antigens.
PLoS One. 2016 Mar 2;11(3):e0150185. doi: 10.1371/journal.pone.0150185. eCollection 2016.
5
Multifunctional CD4⁺ T cells in patients with American cutaneous leishmaniasis.
Clin Exp Immunol. 2012 Mar;167(3):505-13. doi: 10.1111/j.1365-2249.2011.04536.x.
6
Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis.
Inflamm Res. 2012 Mar;61(3):255-63. doi: 10.1007/s00011-011-0407-5. Epub 2011 Dec 14.

本文引用的文献

1
Randomized, double-blind, placebo-controlled study on the immunogenicity of the leishmanin skin test.
Trans R Soc Trop Med Hyg. 2003 Nov-Dec;97(6):709-12. doi: 10.1016/s0035-9203(03)80109-8.
3
Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia.
Trans R Soc Trop Med Hyg. 2005 Aug;99(8):593-8. doi: 10.1016/j.trstmh.2005.04.002.
5
Lipid based particulate formulations for the delivery of antigen.
Immunol Cell Biol. 2005 Apr;83(2):97-105. doi: 10.1111/j.1440-1711.2005.01315.x.
7
Dendritic cells pulsed with peptides of gp63 induce differential protection against experimental cutaneous leishmaniasis.
Int J Immunopathol Pharmacol. 2004 Sep-Dec;17(3):343-52. doi: 10.1177/039463200401700314.
8
New insights into the developmental biology and transmission mechanisms of Leishmania.
Curr Mol Med. 2004 Sep;4(6):601-9. doi: 10.2174/1566524043360285.
9
The T-cell anergy induced by Leishmania amazonensis antigens is related with defective antigen presentation and apoptosis.
An Acad Bras Cienc. 2004 Sep;76(3):519-27. doi: 10.1590/s0001-37652004000300006. Epub 2004 Aug 23.
10
Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review.
Mem Inst Oswaldo Cruz. 2004 May;99(3):239-51. doi: 10.1590/s0074-02762004000300001. Epub 2004 Jul 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验